Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 216

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis

Wilson, Emma H., Wille-Reece, Ulrike, Dzierszinski, Florence, Hunter, Christopher A. · 2005 · Journal of Neuroimmunology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jneuroim.2005.04.018

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 57

  1. Aliberti, 2002, Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection, J. Exp. Med., 196, 1253, 10.1084/jem.20021183 · DOI · Paper page
  2. Belkaid, 2002, CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity, Nature, 420, 502, 10.1038/nature01152 · DOI · Paper page
  3. Berkman, 1995, Inhibition of macrophage inflammatory protein-1-a expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages, J. Immunol., 155, 4412, 10.4049/jimmunol.155.9.4412 · DOI
  4. Blewett, 1983, Simple technique for the direct isolation of toxoplasma tissue cysts from fetal ovine brain, Vet. Rec., 112, 98, 10.1136/vr.112.5.98 · doi:10.1136/vr.112.5.98
  5. Bogdan, 1991, Macrophage deactivation by interleukin 10, J. Exp. Med., 174, 1549, 10.1084/jem.174.6.1549 · DOI · Paper page
  6. Brown, 1995, Definitive identification of a gene that confers resistance against toxoplasma cyst burden and encephalitis, Immunology, 85, 419
  7. Burg, 1989, Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction, J. Clin. Microbiol., 27, 1787, 10.1128/jcm.27.8.1787-1792.1989 · DOI · Paper page
  8. Burke, 1994, Temporal differences in the expression of mRNA for IL-10 and IFN-γ in the brains and spleens of C57BL/10 mice infected with Toxoplasma gondii, Parasite Immunol., 16, 305, 10.1111/j.1365-3024.1994.tb00353.x · DOI
  9. Candolfi, 1995, Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis, Infect. Immun., 63, 751, 10.1128/iai.63.3.751-756.1995 · DOI
  10. Cua, 1999, Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis, J. Exp. Med., 189, 1005, 10.1084/jem.189.6.1005 · DOI · Paper page
  11. de Waal Malefyt, 1991, Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression, J. Exp. Med., 174, 915, 10.1084/jem.174.4.915 · DOI · Paper page
  12. Deckert-Schluter, 1995, Dynamics of the intracerebral and splenic cytokine mRNA production in Toxoplasma gondii-resistant and -susceptible congenic strains of mice, Immunology, 85, 408
  13. Deckert-Schluter, 1997, Interleukin-10 downregulates the intracerebral immune response in chronic toxoplasma encephalitis, J. Neuroimmunol., 76, 167, 10.1016/S0165-5728(97)00047-7 · DOI
  14. Fiorentino, 1991, IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells, J. Immunol., 146, 3444, 10.4049/jimmunol.146.10.3444 · DOI · Paper page
  15. Fischer, 1997, Cytokine responses induced by Toxoplasma gondii in astrocytes and microglial cells, Eur. J. Immunol., 27, 1539, 10.1002/eji.1830270633 · DOI
  16. Fischer, 1999, Differential CD86/B7-2 expression and cytokine secretion induced by Toxoplasma gondii in macrophages from resistant or susceptible BALB H-2 congenic mice, Int. Immunol., 11, 341, 10.1093/intimm/11.3.341 · DOI
  17. Gazzinelli, 1992, IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages, J. Immunol., 148, 1792, 10.4049/jimmunol.148.6.1792 · DOI · Paper page
  18. Gazzinelli, 1992, Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses, Infect. Immun., 60, 4394, 10.1128/iai.60.10.4394-4401.1992 · DOI
  19. Gazzinelli, 1992, Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii, J. Immunol., 149, 175, 10.4049/jimmunol.149.1.175 · DOI · Paper page
  20. Gazzinelli, 1993, Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation, J. Immunol., 151, 3672, 10.4049/jimmunol.151.7.3672 · DOI · Paper page
  21. Gazzinelli, 1996, In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α, J. Immunol., 157, 798, 10.4049/jimmunol.157.2.798 · DOI · Paper page
  22. Halonen, 2000, Investigation into the mechanism of gamma interferon-mediated inhibition of Toxoplasma gondii in murine astrocytes, Infect. Immun., 68, 3426, 10.1128/IAI.68.6.3426-3430.2000 · DOI
  23. Halonen, 1996, Growth and development of Toxoplasma gondii in human neurons and astrocytes, J. Neuropathol. Exp. Neurol., 55, 1150, 10.1097/00005072-199611000-00006 · DOI
  24. Halonen, 1998, Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes, Infect. Immun., 66, 4989, 10.1128/IAI.66.10.4989-4993.1998 · doi:10.1128/iai.66.10.4989-4993.1998
  25. Halonen, 2001, Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP, Infect. Immun., 69, 5573, 10.1128/IAI.69.9.5573-5576.2001 · DOI
  26. Hunter, 1994, Immunopathogenesis of toxoplasmic encephalitis, J. Infect. Dis., 170, 1057, 10.1093/infdis/170.5.1057 · DOI
  27. Hunter, 1992, Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis, Eur. J. Immunol., 22, 2317, 10.1002/eji.1830220921 · DOI
  28. Israelski, 1989, Treatment with anti-L3T4 (CD4) monoclonal antibody reduces the inflammatory response in toxoplasmic encephalitis, J. Immunol., 142, 954, 10.4049/jimmunol.142.3.954 · DOI
  29. Jauregui, 2001, Development of a real-time PCR assay for detection of Toxoplasma gondii in pig and mouse tissues, J. Clin. Microbiol., 39, 2065, 10.1128/JCM.39.6.2065-2071.2001 · DOI
  30. Kelly, 2005, Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection, Infect. Immun., 73, 617, 10.1128/IAI.73.1.617-621.2005 · DOI · Paper page
  31. Kuhn, 1993, Interleukin-10-deficient mice develop chronic enterocolitis, Cell, 75, 263, 10.1016/0092-8674(93)80068-P · DOI · Paper page
  32. Ledeboer, 2002, Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells, Eur. J. Neurosci., 16, 1175, 10.1046/j.1460-9568.2002.02200.x · DOI · Paper page
  33. Lin, 2000, Real-time PCR for quantitative detection of Toxoplasma gondii, J. Clin. Microbiol., 38, 4121, 10.1128/JCM.38.11.4121-4125.2000 · DOI · Paper page
  34. Mendez, 2004, Role for CD4+ CD25+ regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity, J. Exp. Med., 200, 201, 10.1084/jem.20040298 · DOI · Paper page
  35. Murphy, 2001, IL-10 mediates susceptibility to Leishmania donovani infection, Eur. J. Immunol., 31, 2848, 10.1002/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T · DOI · Paper page
  36. Neyer, 1997, Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii, Infect. Immun., 65, 1675, 10.1128/iai.65.5.1675-1682.1997 · DOI · Paper page
  37. Oswald, 1992, IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity, J. Immunol., 148, 3578, 10.4049/jimmunol.148.11.3578 · DOI · Paper page
  38. Padigel, 2003, The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis, J. Immunol., 171, 3705, 10.4049/jimmunol.171.7.3705 · DOI
  39. Qureshi, 2003, IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection, J. Immunol., 170, 1002, 10.4049/jimmunol.170.2.1002 · DOI
  40. Reed, 1994, IL-10 mediates susceptibility to Trypanosoma cruzi infection, J. Immunol., 153, 3135, 10.4049/jimmunol.153.7.3135 · DOI · Paper page
  41. Reichmann, 1999, The CD28/B7 interaction is not required for resistance to Toxoplasma gondii in the brain but contributes to the development of immunopathology, J. Immunol., 163, 3354, 10.4049/jimmunol.163.6.3354 · DOI
  42. Roers, 2004, T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation, J. Exp. Med., 200, 1289, 10.1084/jem.20041789 · DOI · Paper page
  43. Rozenfeld, 2003, Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulated nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration, Infect Immun., 71, 2047, 10.1128/IAI.71.4.2047-2057.2003 · DOI · Paper page
  44. Sander, 1989, Detection of individual interleukin 4- and gamma interferon-producing murine spleen cells after activation with T-cell mitogens, Scand. J. Immunol., 30, 315, 10.1111/j.1365-3083.1989.tb01216.x · doi:10.1111/j.1365-3083.1989.tb01216.x
  45. Schluter, 1997, Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain, Am. J. Pathol., 150, 1021
  46. Sharma, 1983, Western blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies, J. Immunol., 131, 977, 10.4049/jimmunol.131.2.977 · DOI · Paper page
  47. Silva, 1992, Interleukin 10 and interferon-γ regulation of experimental Trypanosoma cruzi infection, J. Exp. Med., 175, 169, 10.1084/jem.175.1.169 · DOI · Paper page
  48. Suzuki, 1988, Interferon-γ: the major mediator of resistance against Toxoplasma gondii, Science, 240, 516, 10.1126/science.3128869 · DOI · Paper page
  49. Suzuki, 1989, Importance of endogenous IFN-γ for prevention of toxoplasmic encephalitis in mice, J. Immunol., 143, 2045, 10.4049/jimmunol.143.6.2045 · DOI · Paper page
  50. Suzuki, 1997, Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice, Infect Immun., 65, 2339, 10.1128/iai.65.6.2339-2345.1997 · DOI
  51. Suzuki, 2000, IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following per oral infection with Toxoplasma gondii, J. Immunol., 164, 5375, 10.4049/jimmunol.164.10.5375 · DOI · Paper page
  52. Turner, 2002, In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice, J. Immunol., 169, 6343, 10.4049/jimmunol.169.11.6343 · DOI · Paper page
  53. Villegas, 2000, Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice, Infect. Immun., 68, 2837, 10.1128/IAI.68.5.2837-2844.2000 · DOI
  54. Wille, 2001, Interleukin-10 does not contribute to the pathogenesis of a virulent strain of Toxoplasma gondii, Parasite Immunol., 23, 291, 10.1046/j.1365-3024.2001.00389.x · DOI
  55. Wille, 2002, Contribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of pathological T-cell response in IL-10-deficient mice, Infect Immun., 70, 6940, 10.1128/IAI.70.12.6940-6947.2002 · doi:10.1128/iai.70.12.6940-6947.2002
  56. Yap, 1999, Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-γ- and tumor necrosis factor (TNF)-α-dependent host resistance to the intracellular pathogen, Toxoplasma gondii, J. Exp. Med., 189, 1083, 10.1084/jem.189.7.1083 · DOI · Paper page
  57. Yap, 1998, Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo, J. Immunol., 160, 1340, 10.4049/jimmunol.160.3.1340 · DOI

Cited by

See all 216

Metadata

Authors
Wilson, E. H., Wille-Reece, U., Dzierszinski, F., & Hunter, C. A.
Venue
Journal of Neuroimmunology
Publisher
Elsevier BV
Published
2005-08
Volume
165
Issue
1-2
Pages
63-74
ISSN
0165-5728 (ISSN-L)
OpenAlex
W2079409189
Cited by
216
References
4
FWCI
5.54
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. https://app.cochat.ai/papers/10.1016/j.jneuroim.2005.04.018
The paper
Wilson, E. H., Wille-Reece, U., Dzierszinski, F., & Hunter, C. A. (2005). A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. Journal of Neuroimmunology. https://doi.org/10.1016/j.jneuroim.2005.04.018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.